gma semaglutide is a medication that was initially approved for Type 2 diabetes, but is now allowed to be prescribed for weight loss too. MORE on what happens when you stop taking it Weight loss drugs in next

Another study found that there was an even higher risk of developing hypothyroidism in patients with type 1 diabetes who also had TPO antibodies they were 18 times more likely to develop hypothyroidism compared to patients with type 1 diabetes without TPO antibodies

This reduction was noted with the wanting subtype of reward eating in women greater so than men

Well break down the similarities and differences between liraglutide and semaglutide, from how they work and their side effects to cost, coverage, and which may be better suited to your goals

Read all the stories in WIREDs The Age of Ozempic series

Reduced Risk of Major Cardiovascular Events Clinical trials, such as the SUSTAIN-6 and PIONEER-6 studies, have demonstrated that Semaglutide can reduce the risk of major cardiovascular events, such as heart attack, stroke, and cardiovascular-related death